Impact of tuberculosis disease on human gut microbiota: a systematic review.
Tejaswini BaralShilia Jacob KurianLevin ThomasChandrashekar Udyavara KudruChiranjay MukhopadhyayKavitha SaravuMohan K ManuJitendra SinghMurali MunisamyAmit KumarBidita KhandelwalMahadev RaoSonal Sekhar MirajPublished in: Expert review of anti-infective therapy (2022)
The modulation of GM in TB patients in clinical practice may serve as a promising target to reverse the dysbiosis caused. Moreover, this can optimistically change the TB treatment outcome. We expect that appropriate probiotics supplementation with antimycobacterial treatment during tuberculosis disease will help stabilize the GM throughout the treatment phase and protect the GM from dysbiosis.